1. "Biocompatible cross-linked gel"
The invention relates to a method for producing a biocompatible cross-linked gel of hyaluronic acid or one of the salts thereof. This method for producing such a gel allows Anteis to design new products with superior viscoelastic characteristics. The technologies and products which came out of this patented production method was CPM and Esthélis, EVE and Fortélis, HPM and Modélis.
2. "Viscoelastic gel for dermatological use"
The invention concerns a natural dermatological polysaccharide gel comprising a polysaccharide aqueous solution (for example, a hyaluronic acid) and a biocompatible viscous highly hydrophilic alcohol (for example, a glycérol) and possibly, adjuvants used in dermatology. The association of HA and glycérol provides superior hydration capabilities compared to regular formulations. Mesolis + was the first development to take advantage of this patent application.
3. "Use of a natural polysaccharide gel for the preparation of an injectable formulation for treatment of articular degeneration"
The invention concerns a sterile injectable aqueous formulation in the form of a gel made up of hyaluronic acid with or whithout other natural polysaccharide(s) and one or more polyols.
The formulation is of intra-articular application in the treatment of joint degeneration. It has a rheology similar to that of synovial liquid and an elevated resistance to degradation due to a synergistic action between the hyaluronic acid and the polyols. Synolis was the first development to take advantage of this patent application.
4. "Injectable hydrogel with an enhanced lasting and with an enhanced ability to create volume"
The invention concerns an injectable hydrogel wich includes a hydrogel matrix based on single-phase-type cross-linked biopolymer(s), characterized in that previously cross-linked biopolymer hydrogel particles are co-cross-linked with the matrix. A method of and a process for production of the above-mentioned hydrogel are also disclosed.
5. "Injectable hydrogel for the long-term supplementation of glycérol in the skin"
The invention relates to an injectable hydrogel including cross-linked hyaluronic acid and glycérol for a long-term supplementation of glycérol in the skin.
6. "Assited injection device"
The invention relates to an assisted injection device to inject viscoelastic gels. The Anteis Injection System was the first development to take advantage of this patent application.
7. "Heat sterilised injectable composition of hyaluronic acid, polyols and lidocaine"
The invention concerns an injectable aqueous composition of hyaluronic acid, some polyols and lidocaine for cosmetic purposes or for therapeutic purposes. This composition has improved viscoelastic rheological properties and long in vivo persistence.
recommendprint this page top